我院2004～2008年保肝药应用分析

Analysis on Utilization of Liver-protective Medicines in Our Hospital During 2004～2008

目的:评价我院保肝药的应用状况及趋势。方法:采用销售金额和用药频度(DDDs)等方法,对我院2004～2008年保肝药的应用情况进行统计、分析。结果:我院保肝药销售金额占药品总销售金额的比例平均为21.09%,2004～2005年防治抗结核药物性肝损害的主要药品为肌苷,2006～2008年新的、昂贵品种应用增多,销售金额大幅攀升。结论:我院2004～2005年保肝药应用较经济、合理,2006～2008年用药档次提高,应加强干预,以恢复到较为经济、合理的水平。

OBJECTIVE： To analyze status quo of utilization of liver-protective medicines in our hospital. METHODS ： Consumption sum and DDDs of liver-protective medicines were analyzed statistically in our hospital during 2004-2008. RESULTS： The proportion of consumption sum of liver-protective medicines in total was 21.09%. The main medicines was inosine to prevent antituberculosis druginduced hepatic lesion during 2004-2005. The utilization of new and expensive liver-protective medicines was used more than before during 2006-2008. The consumption sum was increased greatly. CONCLUSION： The utilization of liver-protective medicines is rational and economical in the previous two years. But the price of used liver-protective medicines is higher than before during 2006-2008. So some interventions should be adopted to control the utilization of liver-protective medicines rationally and economically.